These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2592590)

  • 1. Characterizing anticholinergic abuse in community mental health.
    Wells BG; Marken PA; Rickman LA; Brown CS; Hamann G; Grimmig J
    J Clin Psychopharmacol; 1989 Dec; 9(6):431-5. PubMed ID: 2592590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abuse potential of anticholinergics.
    Dose M; Tempel HD
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():43-6. PubMed ID: 11072764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotics use in drug abuse].
    Ochoa Mangado E
    Actas Esp Psiquiatr; 2001; 29(3):172-85. PubMed ID: 11412492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs.
    McEvoy JP
    J Clin Psychopharmacol; 1983 Oct; 3(5):288-302. PubMed ID: 6138370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anticholinergic drug withdrawal on memory, regional cerebral blood flow and extrapyramidal side effects in schizophrenic patients.
    Mori K; Yamashita H; Nagao M; Horiguchi J; Yamawaki S
    Pharmacopsychiatry; 2002 Jan; 35(1):6-11. PubMed ID: 11819152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
    Sankaranarayanan J; Puumala SE
    Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team - final results.
    Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
    Psychiatr Danub; 2007 Sep; 19(3):130-8. PubMed ID: 17914313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
    Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and abuse of anticholinergic drugs in psychiatry.
    Gelenberg AJ
    Hillside J Clin Psychiatry; 1984; 6(2):148-55. PubMed ID: 6396187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use or abuse of antiparkinsonian drugs by psychiatric patients.
    Saran AS
    J Clin Psychiatry; 1986 Mar; 47(3):130-2. PubMed ID: 2869028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
    Bransgrove LL; Kelly MW
    Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE).
    Fischer-Barnicol D; Lanquillon S; Haen E; Zofel P; Koch HJ; Dose M; Klein HE;
    Neuropsychobiology; 2008; 57(1-2):80-7. PubMed ID: 18515977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.
    Wynchank D; Berk M
    Hum Psychopharmacol; 2003 Jun; 18(4):271-5. PubMed ID: 12766931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.